Search Tag: PSP

ICU Management

Applying-international-sepsis-guidelines-by-screening-high-risk-hospitalised-patients-with-psp

2023 13 Oct

Hospital and ICU nosocomial sepsis screening for acutely ill and high-risk patients and daily measurement of PSP to diagnose nosocomial sepsis three to five days before the onset of symptoms.     Introduction Sepsis is a major public health threat and is responsible for 11 million deaths per year (Rudd et al. 2020) among 48.9 million cases....Read more

Sepsis

Improving-sepsis-care-insights-from-dr-philippe-eggimann-at-isicem-2023

2023 20 Apr

The International Symposium on Intensive Care and Emergency Medicine (ISICEM) is a renowned event in the medical industry, bringing together professionals from all over the world to discuss the latest developments and advancements in critical care and emergency medicine. This year's event took place from 21 to 24 April 2023 in Brussels.   One...Read more

ICU Management

Biomarkers-as-prognostic-predictors-and-guide-in-critically-ill-patients-1

2023 20 Apr

An overview of promising biomarkers in critical care, characteristics a biomarker should have and how to ensure their usefulness in clinical practice.   Introduction   Precision medicine is a medical approach that tailors treatments based on individual patient characteristics and their unique response to therapies for a particular disease....Read more

Sepsis

Nanofluidic-technology-enables-rapid-quantification-of-psp-as-an-early-biomarker-of-sepsis

2023 01 Feb

In-vitro diagnostic tests allow for quick results and prompt decision-making by medical professionals in near-patient settings. The abioSCOPE® device uses nanofluidic technology to quickly measure the number of molecules in a sample using a small amount of fluid and minimal preparation, resulting in fast results. Pancreatic stone protein (PSP) is a...Read more

ICU Management

Guiding-clinical-care-using-pancreatic-stone-protein-1

2022 08 Dec

The role of point-of-care testing in the early identification and management of sepsis, the need for better markers to identify sepsis, an overview of the Pancreatic Stone Protein (PSP) and clinical evidence highlighting its effectiveness as a biomarker. Pancreatic Stone Protein Infections are a leading cause of morbidity and mortality...Read more

Sepsis

Pancreatic-stone-protein-for-predicting-perioperative-infection-in-cardiac-surgery

2022 06 Dec

According to the Surviving Sepsis Campaign (SSC), sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. The organ dysfunction may be transitory in some patients, but complications can always occur in others. For example, a patient who has undergone cardiac surgery can present postoperative cardiac dysfunction,...Read more

Sepsis

Pancreatic-stone-protein-testing-reduces-expenditure-in-sepsis

2022 02 Aug

Sepsis is a life-threatening organ dysfunction and a cause of significant morbidity and mortality. In addition, the high number of sepsis cases is a significant economic burden for healthcare systems. Statistics show that sepsis was the most expensive condition treated in the U.S. in 2013, costing nearly $24 billion. An analysis of Medicare claims...Read more

Sepsis

Accuracy-of-pancreatic-stone-protein-for-diagnosis-of-infection

2022 12 Jul

Severe infections cause significant morbidity and mortality among hospitalised patients. Early detection of life-threatening infections is crucial to improving outcomes. However, none of the circulating blood biomarkers that have been investigated have been found to detect life-threatening infection quickly or accurately. Despite sub-optimal results,...Read more

Sepsis

Pancreatic-stone-protein-psp-sepsis-test-on-the-abioscope-r-point-of-care-platform

2022 06 Jun

1. Sepsis: the Need for Speed Sepsis is a life-threatening form of organ dysfunction caused by a dysregulated host response to infection 1 . This extremely heterogeneous and dynamic syndrome is the result of complex interactions between invading microorganisms and the host’s immune system. Disruption of the host’s ability to maintain immune homeostasis...Read more

ICU Management

Practical-implementation-of-the-pancreatic-stone-protein-sepsis-test

2022 25 May

An overview of a discussion on sepsis and the Pancreatic Stone Protein (PSP) biomarker by Dr João Pereira, Hospital De Vila Franca De Xira, Portugal and how it can be used for early diagnosis of sepsis and facilitate decision-making regarding the administration of antibiotics. The discussion was chaired by Prof Pedro Póvoa, coordinator of...Read more

Sepsis

Abionics-unique-sepsis-detection-solution-1

2022 21 Apr

Based in Switzerland, Abionic is an in vitro diagnostic company, uniquely positioned at the intersection of medical technology, biotechnology and nanotechnology. The company has developed an unparalleled nanofluidic technology-based platform, the abioSCOPE® to offer patients fast blood test results right at the Point-of-Care (PoC). The abioSCOPE® is...Read more

Sepsis

Abionic-webinar-advancing-the-diagnosis-of-sepsis-in-the-intensive-care-units-2

2021 04 Oct

Real world evidence on the practical implementation of the Pancreatic Stone Protein (PSP) Sepsis Test   On the 22nd of September, attendees tuned in to a lively discussion on sepsis chaired by Professor Pedro Póvoa, who is currently coordinator of the Intensive Care Unit (ICU) in one of the largest hospitals in Lisbon and who is no stranger to the...Read more

ICU Management

Abionic-webinar-advancing-the-diagnosis-of-sepsis-in-the-intensive-care-units-3

2021 04 Oct

Real world evidence on the practical implementation of the Pancreatic Stone Protein (PSP) Sepsis Test   On the 22nd of September, attendees tuned in to a lively discussion on sepsis chaired by Professor Pedro Póvoa, who is currently coordinator of the Intensive Care Unit (ICU) in one of the largest hospitals in Lisbon and who is no stranger to the...Read more

ICU Management

New-data-confirms-the-clinical-benefit-of-psp-for-the-diagnosis-of-severe-infections-2

2021 28 May

Critical Care, the top-ranked open access journal in the field of critical care medicine, published the results of a study led by Lausanne University Hospital’s Dr Philippe Eggimann and Bern University Hospital’s Dr Yok-Ai Que this month [1]. The authors analyzed pooled data from five cohorts showing that the Pancreatic stone protein (PSP) biomarker...Read more

Sepsis

New-data-confirms-the-clinical-benefit-of-psp-for-the-diagnosis-of-severe-infections

2021 28 May

Critical Care, the top-ranked open access journal in the field of critical care medicine, published the results of a study led by Lausanne University Hospital’s Dr Philippe Eggimann and Bern University Hospital’s Dr Yok-Ai Que this month [1]. The authors analyzed pooled data from five cohorts showing that the Pancreatic stone protein (PSP) biomarker...Read more

Sepsis

The-psp-biomarker-rises-earlier-than-crp-and-pct-in-sepsis-a-new-study-shows

2021 20 Apr

Sepsis is a global healthcare problem, with 50 million cases each year and 11 million related deaths  1 . It’s the life-threatening complication of an infection, in which the host’s immune response to a pathogen damages its own organs. The clinical diagnosis of sepsis relies mostly on signs and symptoms that are neither sensitive nor specific enough...Read more

ICU Management

Early-identification-of-sepsis-web-symposium

2020 17 Nov

Speakers Prof. Dr Steven Opal Alpert Medical School of Brown University, USA Dr Bruno Francois Centre Hospitalier Universitaire de Limoges, France Dr Angelo Giacomucci Unita di Terapia Intensiva, Azienda Ospedaliera di Perugia, Italy Dr Phillipe Eggimann Centre Hopsitalier Universitaire Vaudois, Switzerland   Find Abionic on Social...Read more